Back to Startup Insights
Mallia Innovations GmbH
Mallia Innovations develops novel treatments based on soluble CD83 (sCD83) protein to treat hair loss and dermatological conditions.
Headquarters
Hamburg, Germany
Year Founded
2023
Founders
Dr. Sabine Keller
Country
Germany
Financial Information
Funding Stage
Seed
Recent Funding
$2.23 M
Funding By
DermInvest
Core Technology
sCD83 for dermatology
Product Type
Drug
Pipeline Stage (Very Important)
Preclinical
Regulatory Status
- IND Filed: No
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Filed
Partnerships
Pharma Collaborations
None
Academic / Hospital Tie-ups
Hamburg University
CRO/CDMO Partnerships
None
Market & Differentiation
Dermatology sCD83